- TRANSGENE BIOTEK LTD
TRANSGENE BIOTEK LTD
BSE: 526139
₹3.54
-₹0.07 (-1.94%) TodayLast updated on 05 May, 2025 | 15:15 ISTMarket cap  ₹27 Crs | Open ₹3.54 | Prev. Close ₹3.61 |
Circuit range ₹3.68 - ₹3.54 | Day range ₹3.54 - ₹3.54 | Year range ₹3.22 - ₹10.84 |
Volume 15,840 | Avg. traded ₹3.54 | Revenue (12m) ₹0 Crs |
About TRANSGENE BIOTEK LTD
Transgene Biotek Limited is an India-based biotechnology company. It is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products includes oncology, autoimmunity, drug delivery and biogenetics. The Company offers TrabiAAV, which is a platform for the delivery of micro-ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL drug is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203 drug is used to strengthen cell-mediated immunity and complete the elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus drug suppresses the immune system and is mainly used to prevent rejection of transplanted organs.
TRANSGENE BIOTEK LTD Share Price Chart
Please wait...
TRANSGENE BIOTEK LTD Fundamentals
TRANSGENE BIOTEK LTD Key indicators
52 week high ₹10.84 | 52 week low ₹3.22 | P/E ratio |
P/B ratio 2.69 | ROE -- | ROCE -7.35% |
Dividend yield -- | Debt/Equity ratio -2.04 | EPS -0.09 |
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
TRANSGENE BIOTEK LTD Financial Ratios
Operating profit margin-180.33% | Net profit margin-279.05% |
ROE0% | ROA-2.02% |
ROCE-7.35% |
Quick ratio0.1 | Current ratio0.1 |
Interest coverage-3.7 | Asset turnover0.01 |
Debt to Equity-2.04 |
P/E ratio0 | P/B ratio2.69 |
EV / EBITDA-178.64 | |
Dividend yield0% |
Revenue statement
All values are in ₹ Crores (Cr)
Loading chart data
Cash flow
All values are in ₹ Crores (Cr)
Loading chart data
Balance sheet
All values are in ₹ Crores (Cr)
No data available at the moment
Total assets
Total liabilities
TRANSGENE BIOTEK LTD Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Mon, May 5 2025 | ₹3.54 | ₹3.54 | -1.94% |
Fri, May 2 2025 | ₹3.61 | ₹3.61 | -1.90% |
Wed, Apr 30 2025 | ₹3.68 | ₹3.68 | -1.87% |
Tue, Apr 29 2025 | ₹3.75 | ₹3.75 | -1.83% |
Mon, Apr 28 2025 | ₹3.88 | ₹3.82 | -1.80% |
Fri, Apr 25 2025 | ₹3.90 | ₹3.89 | -0.26% |
Thu, Apr 24 2025 | ₹3.91 | ₹3.90 | -0.26% |
Wed, Apr 23 2025 | ₹3.91 | ₹3.91 |
More
Stocks Similar to TRANSGENE BIOTEK LTD
Popular Stocks
TRANSGENE BIOTEK LTD News
FAQs on TRANSGENE BIOTEK LTD
What is the TRANSGENE BIOTEK LTD share price today?
TRANSGENE BIOTEK LTD share price is ₹ 3.54 as on 06 May, 2025 | 00:05 IST
What is today’s high & low share price of TRANSGENE BIOTEK LTD?
TRANSGENE BIOTEK LTD share price high: ₹ 3.54 and low: ₹ 3.54 as on 06 May, 2025 | 00:05 IST
What is the TRANSGENE BIOTEK LTD share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 10.84 and Low Price is ₹ 3.22 as on 06 May, 2025 | 00:05 IST
What is the TRANSGENE BIOTEK LTD Stock Symbol?
The TRANSGENE BIOTEK LTD Stock symbol is TRABI.
Can I buy TRANSGENE BIOTEK LTD shares on Holidays?
No, shares of TRANSGENE BIOTEK LTD or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell TRANSGENE BIOTEK LTD shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.